Research Reflections: Barzi Reviews CRC Updates From ASCO GI 2022
Season 6, Episode 37, Mar 24, 2022, 07:54 PM
Dr Barzi discusses data from the ACCENT and RESPECT trials evaluating the value of oxaliplatin for patients with colorectal cancer, results from an investigation of nivolumab plus ipilimumab for patients with high tumor mutational burden, and more.